Icodextrin in Peritoneal Dialysis: Implications on Clinical Practice and Survival Outcome.
作者信息
Ng Jack Kit-Chung, Chan Gordon Chun-Kau, Li Philip Kam-Tao
机构信息
Carol and Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, P.R. China.
出版信息
Kidney360. 2022 Apr 19;3(5):793-795. doi: 10.34067/KID.0001902022. eCollection 2022 May 26.
Abstract
摘要
相似文献
1
Icodextrin in Peritoneal Dialysis: Implications on Clinical Practice and Survival Outcome.腹膜透析中使用艾考糊精：对临床实践及生存结局的影响
Kidney360. 2022 Apr 19;3(5):793-795. doi: 10.34067/KID.0001902022. eCollection 2022 May 26.
2
Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.依克多因通过改善体液管理提高糖尿病肾病腹膜透析患者的技术生存率：一项随机对照试验。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1337-44. doi: 10.2215/CJN.10041110. Epub 2011 Apr 14.
3
Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.艾考糊精作为腹膜透析难治性液体超负荷患者的挽救治疗方法。
BMC Nephrol. 2001 Dec 3;2:2. doi: 10.1186/1471-2369-2-2.
4
Icodextrin: a review of its use in peritoneal dialysis.艾考糊精：其在腹膜透析中应用的综述
Drugs. 2003;63(19):2079-105. doi: 10.2165/00003495-200363190-00011.
5
Early quality of life benefits of icodextrin in peritoneal dialysis.艾考糊精在腹膜透析中对早期生活质量的益处
Kidney Int Suppl. 2002 Oct(81):S72-9. doi: 10.1046/j.1523-1755.62.s81.10.x.
6
Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.钠清除和腹膜透析方式：与最佳的艾考糊精处方无差异。
Artif Organs. 2013 Jul;37(7):E107-13. doi: 10.1111/aor.12061. Epub 2013 Mar 5.
7
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3.
8
Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.艾考糊精可降低腹膜透析患者的技术失败率并提高患者生存率。
Nephrology (Carlton). 2015 Mar;20(3):161-7. doi: 10.1111/nep.12375.
9
Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry.澳大利亚艾考糊精用于腹膜透析的情况：一项利用澳大利亚和新西兰透析与移植登记处数据的队列研究。
Perit Dial Int. 2020 Mar;40(2):209-219. doi: 10.1177/0896860819894058. Epub 2020 Jan 17.
10
Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.循环辅助腹膜透析与持续非卧床腹膜透析的容量超负荷比较。
Clin J Am Soc Nephrol. 2009 Jun;4(6):1044-50. doi: 10.2215/CJN.00020109. Epub 2009 Apr 30.
引用本文的文献
1
Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities.腹膜透析相关性纤维化：新出现的机制与治疗机会
Front Pharmacol. 2025 Aug 22;16:1635624. doi: 10.3389/fphar.2025.1635624. eCollection 2025.
2
Analysis of risk factor for peritonitis in peritoneal dialysis patients.腹膜透析患者腹膜炎危险因素分析。
Am J Transl Res. 2024 Nov 15;16(11):6964-6971. doi: 10.62347/EDBZ3412. eCollection 2024.
本文引用的文献
1
International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival.国际艾考糊精的使用与腹膜功能、液体清除、患者和技术生存的关系。
Kidney360. 2022 Mar 1;3(5):872-882. doi: 10.34067/KID.0006922021. eCollection 2022 May 26.
2
The impact of volume overload on technique failure in incident peritoneal dialysis patients.容量超负荷对新发腹膜透析患者技术失败的影响。
Clin Kidney J. 2019 Dec 22;14(2):570-577. doi: 10.1093/ckj/sfz175. eCollection 2021 Feb.
3
Volume management as a key dimension of a high-quality PD prescription.作为高质量 PD 处方的关键维度，容量管理。
Perit Dial Int. 2020 May;40(3):282-292. doi: 10.1177/0896860819895365. Epub 2020 Jan 17.
4
Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.艾考糊精与葡萄糖溶液在每日一次长时腹膜透析中的应用：一项基于随机对照试验的系统评价和荟萃分析。
Am J Kidney Dis. 2020 Jun;75(6):830-846. doi: 10.1053/j.ajkd.2019.10.004. Epub 2020 Feb 4.
5
Evolution Over Time of Volume Status and PD-Related Practice Patterns in an Incident Peritoneal Dialysis Cohort.时间推移中容量状态和 PD 相关实践模式在一个新发生腹膜透析队列中的演变。
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):882-893. doi: 10.2215/CJN.11590918. Epub 2019 May 23.
6
Icodextrin Is Associated with a Lower Mortality Rate in Peritoneal Dialysis Patients.艾考糊精可降低腹膜透析患者的死亡率。
Perit Dial Int. 2019 May-Jun;39(3):252-260. doi: 10.3747/pdi.2018.00217. Epub 2019 Mar 9.
7
Fluid management and bioimpedance study in peritoneal dialysis.腹腔透析中的液体管理和生物阻抗研究。
Curr Opin Nephrol Hypertens. 2019 Jan;28(1):58-64. doi: 10.1097/MNH.0000000000000466.
8
Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients.无症状性液体超负荷可预测新入组的中国腹膜透析患者的生存和心血管事件。
PLoS One. 2018 Aug 13;13(8):e0202203. doi: 10.1371/journal.pone.0202203. eCollection 2018.
9
Fluid Overload in Peritoneal Dialysis Patients.腹膜透析患者的液体超负荷
Semin Nephrol. 2017 Jan;37(1):43-53. doi: 10.1016/j.semnephrol.2016.10.006.
10
Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.腹膜透析的低GDP解决方案与葡萄糖节约策略
Semin Nephrol. 2017 Jan;37(1):30-42. doi: 10.1016/j.semnephrol.2016.10.005.
Zotero 插件